Holen Sie sich die Stockscreener-App
0.2304
3.32%
0.0074
Handel nachbörslich:
.24
0.0096
+4.17%
AIM ImmunoTech Inc Aktie (AIM) Neueste Nachrichten
AIM ImmunoTech Inc. (AMEX:AIM) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: AIM ImmunoTech reports progress on Ampligen, eyes partnerships - Investing.com India
AIM ImmunoTech Inc (AIM) Q3 2024 Earnings Call Highlights: Strat - GuruFocus.com
AIM ImmunoTech Inc (AIM) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance
Aim Immunotech Reports Third Quarter Earnings - TipRanks
AIM ImmunoTech files to sell 9.31M shares of common stock for holders - TipRanks
AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
AIM Down on Q3 Results - Baystreet.ca
AIM ImmunoTech reports Q3 EPS (6c), consensus (9c) - TipRanks
Q3 2024 AIM ImmunoTech Inc Earnings Call Transcript - GuruFocus.com
AIM ImmunoTech Cuts Q3 Losses by 52%, Advances Pancreatic Cancer Treatment Program | AIM Stock News - StockTitan
AIM ImmunoTech Inc. (AIM) Quarterly 10-Q Report - Quartzy
ARMISTICE CAPITAL, LLC Acquires Additional Shares in AIM ImmunoT - GuruFocus.com
AIM ImmunoTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AIM ImmunoTech stockholder Kellner Group issues letter on Board vote - TipRanks
AIM Immunotech's Largest Shareholder Fights Board After 99% Stock Collapse | AIM Stock News - StockTitan
Ted D Kellner Files Definitive Proxy Statement with Securities and Exchange Commission - Marketscreener.com
AIM ImmunoTech to Discuss Third Quarter 2024 Financial - GlobeNewswire
AIM ImmunoTech Sets Q3 2024 Earnings Call: Key Updates Expected Nov 15 | AIM Stock News - StockTitan
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders - messenger-inquirer
AIM ImmunoTech Files Definitive Proxy Statement with Securities and Exchange Commission - Marketscreener.com
AIM ImmunoTech Solicits Proxies from Shareholders - Marketscreener.com
Ted D. Kellner Files Preliminary Proxy Statement with Securities and Exchange Commission - Marketscreener.com
AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC - GlobeNewswire
Was there any good news for AIM ImmunoTech Inc (AIM) stock in the last session? - US Post News
AIM ImmunoTech Inc [AIM] Shares Fall -1.22 % on Thursday - Knox Daily
Ratios in Focus: Analyzing AIM ImmunoTech Inc (AIM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis - The Manila Times
AIM ImmunoTech Inc’s latest rating changes from various analysts - Knox Daily
AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment - Marketscreener.com
AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering - The Manila Times
AIM ImmunoTech sees promising results in Ampligen combo for pancreatic cancer - MSN
AIM Stock Sees Decline of Approximately -18.54% in Last Five Days - Knox Daily
The Future of AIM ImmunoTech Inc: Analyzing AIM - The InvestChronicle
Deeper Dive: Understanding AIM ImmunoTech Inc (AIM) Through its Various Ratios - The Dwinnex
AIM ImmunoTech (NYSE:AIM) Shares Up 4.5% - Defense World
Hsbc Holdings PLC Increases Stock Holdings in Applied Industrial Technologies, Inc. (NYSE:AIT) - MarketBeat
AIM Under Threat? LSE Chief Raises Alarm - AskTraders
London Stock Exchange boss warns AIM is under threat of collapse - City A.M.
AIM future in doubt if business relief removed warns LSE chief - Proactive Investors Australia
Budget tax threat raises questions over AIM’s future - Financial News
Benjamin Edwards Inc. Has $318,000 Stake in Acuity Brands, Inc. (NYSE:AYI) - Defense World
AIM stock touches 52-week low at $0.25 amid market challenges - Investing.com Australia
Taking a look at what insiders are doing to gauge the AIM ImmunoTech Inc (AIM)’s direction - Knox Daily
Analyzing the Impact of Earnings Reports on AIM ImmunoTech Inc Inc. (AIM) Price Performance - The InvestChronicle
The future of AIM: how the small-cap market can survive - Interactive Investor
AIM ImmunoTech Inc (AIM) presents a great opportunity, but the stock is slightly undervalued - US Post News
Investor’s Delight: AIM ImmunoTech Inc (AIM) Closes Weak at 0.29, Down -2.45 - The Dwinnex
Clear Street LLC Takes Position in Aimfinity Investment Corp. I (NASDAQ:AIMBU) - Defense World
AIMAIM ImmunoTech Inc. Latest Stock News & Market Updates - StockTitan
AIM ImmunoTech Reports Positive Preliminary Data in Phase - GlobeNewswire
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer - StockTitan
Aim ImmunoTech CEO acquires $1.5k in company stock By Investing.com - Investing.com Canada
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):